These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8916191)

  • 1. Lack of interaction between devazepide and 8-OH-DPAT-induced hyperphagia in the rat.
    Francis J; Dourish CT; Cooper SJ
    Physiol Behav; 1996 Nov; 60(5):1337-40. PubMed ID: 8916191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the CCKA antagonist devazepide on eating stimulated by raphe injection of 8-OH-DPAT.
    Currie PJ; Coscina DV
    Neuroreport; 1995 Dec; 7(1):253-6. PubMed ID: 8742464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a nitric oxide synthase inhibitor on 5-HT1A receptor agonist 8-OH-DPAT-induced hyperphagia in rats.
    Yamada J; Sugimoto Y; Yoshikawa T; Horisaka K
    Eur J Pharmacol; 1996 Nov; 316(1):23-6. PubMed ID: 8982645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adrenalectomy on hyperphagia induced by the 5-HT1A receptor agonist 8-OH-DPAT and 2-deoxy-D-glucose in rats.
    Yamada J; Sugimoto Y; Yoshikawa T
    Neuroreport; 1998 Jun; 9(8):1831-3. PubMed ID: 9665610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the involvement of the 5-HT1A receptor in CCK induced satiety in rats.
    Voigt JP; Fink H; Marsden CA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Mar; 351(3):217-20. PubMed ID: 7609773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
    Corp ES; Curcio M; Gibbs J; Smith GP
    Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
    Ebenezer IS; Baldwin BA
    Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Devazepide attenuates dl-fenfluramine-induced suppression of gastric emptying but not food intake in the 17 h food-deprived rat.
    Francis J; Dourish CT; Cooper SJ
    Physiol Behav; 1997 Sep; 62(3):545-50. PubMed ID: 9272662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors.
    Hutson PH; Dourish CT; Curzon G
    Eur J Pharmacol; 1988 Jun; 150(3):361-6. PubMed ID: 2970974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats.
    Eberle-Wang K; Simansky KJ
    Pharmacol Biochem Behav; 1992 Nov; 43(3):943-7. PubMed ID: 1448490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory Role of Postsynaptic 5-Hydroxytryptamine Type 1A Receptors in (±)-8-Hydroxy-N,N-dipropyl-2-aminotetralin-Induced Hyperphagia in Mice.
    Brosda J; Müller N; Bert B; Fink H
    ACS Chem Neurosci; 2015 Jul; 6(7):1176-85. PubMed ID: 25781502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with the 5-HT1A receptor agonists 8-OH-DPAT or gepirone does not attenuate the inhibitory effect of systemically administered cholecystokinin (CCK) on food intake in rats.
    Ebenezer IS; Brooman J
    Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):589-95. PubMed ID: 7760584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake.
    Tomkins DM; Higgins GA; Sellers EM
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):173-9. PubMed ID: 7862892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.
    Josselyn SA; Franco VP; Vaccarino FJ
    Psychopharmacology (Berl); 1996 Jan; 123(2):131-43. PubMed ID: 8741936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
    Ballaz S; Barber A; Fortuño A; Del Río J; Martin-Martínez M; Gómez-Monterrey I; Herranz R; González-Muñiz R; García-López MT
    Br J Pharmacol; 1997 Jun; 121(4):759-67. PubMed ID: 9208145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of CCK and 8-OH-DPAT in the satiation of alcohol intake.
    Kulkosky PJ; Allison CT; Allison TG; Marquez LM; Mattson BJ
    Alcohol; 1998 Nov; 16(4):305-9. PubMed ID: 9818982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.
    Hutson PH; Dourish CT; Curzon G
    Eur J Pharmacol; 1986 Oct; 129(3):347-52. PubMed ID: 2430815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of WAY-100135 and 8-hydroxy-2-(di-n-propylamino)tetralin on feeding in the rat.
    Hartley JE; Fletcher A
    Eur J Pharmacol; 1994 Feb; 252(3):329-32. PubMed ID: 8162954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Devazepide increases food intake in male but not female Zucker rats.
    Strohmayer AJ; Greenberg D
    Physiol Behav; 1996 Jul; 60(1):273-5. PubMed ID: 8804675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.